D C Heaton1, D Y Han, A Inder. 1. Department of Haematology, Christchurch Hospital, University of Otago, New Zealand.
Abstract
BACKGROUND:Central vein catheters, which are used in the treatment of cancer patients, are prone to thrombotic complications of the catheter or adjacent vein. Previous studies suggest that 1 mg warfarin daily (minidose) can significantly reduce that risk. AIMS: This, study aims to establish whether minidose warfarin could reduce catheter-related thrombosis in adult patients with haematological malignancies. METHODS: Patients were randomly selected to receive warfarin or not. The end-points studied were: (i) occlusion by thrombus, (ii) removal of catheter for other reasons or (iii) 90 days free of thrombus. RESULTS: There was no significant difference in the incidence of catheter thrombosis or venous thrombosis and no significant variation in catheter survival between the study and control groups. CONCLUSIONS: This study found no benefit of the routine use of minidose warfarin for prophylaxis of central vein' catheter thrombosis in patients with haematological malignancies and therefore does not support the routine use of minidose warfarin for prophylaxis in such patients.
RCT Entities:
BACKGROUND: Central vein catheters, which are used in the treatment of cancerpatients, are prone to thrombotic complications of the catheter or adjacent vein. Previous studies suggest that 1 mg warfarin daily (minidose) can significantly reduce that risk. AIMS: This, study aims to establish whether minidose warfarin could reduce catheter-related thrombosis in adult patients with haematological malignancies. METHODS:Patients were randomly selected to receive warfarin or not. The end-points studied were: (i) occlusion by thrombus, (ii) removal of catheter for other reasons or (iii) 90 days free of thrombus. RESULTS: There was no significant difference in the incidence of catheter thrombosis or venous thrombosis and no significant variation in catheter survival between the study and control groups. CONCLUSIONS: This study found no benefit of the routine use of minidose warfarin for prophylaxis of central vein' catheter thrombosis in patients with haematological malignancies and therefore does not support the routine use of minidose warfarin for prophylaxis in such patients.
Authors: Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei Journal: Vasc Health Risk Manag Date: 2007
Authors: Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint Journal: Clin Infect Dis Date: 2011-04-01 Impact factor: 9.079
Authors: Giuseppe Curigliano; Alessandra Balduzzi; Anna Cardillo; Raffaella Ghisini; Giulia Peruzzotti; Laura Orlando; Rosalba Torrisi; Silvia Dellapasqua; Loredana Lunghi; Aron Goldhirsch; Marco Colleoni Journal: Support Care Cancer Date: 2007-06-20 Impact factor: 3.603